The clinical outcomes associated with Zika virus (ZIKV) in the Americas have been well documented, but other aspects of the pandemic, such as attack rates and risk factors, are poorly understood.
As several Zika virus vaccine candidates undergo clinical trials, a group of investigators is taking an alternate approach to quell transmission by genetically engineering mosquitoes to be resistant to the virus.
Researchers identified space-time clusters of dengue, chikungunya, and Zika, to understand the dynamics and interaction between these simultaneously circulating arboviruses in a densely populated and heterogeneous city.
Thousands of Zika virus cases went unreported in Cuba in 2017, according to an analysis of data on travelers to the Caribbean island. Veiling them may have led to many other cases that year.
The Nebraska scientists used two forms of weakened Adenovirus to serve as vectors to deliver the Zika vaccine.
No drugs are currently available to treat Ebola, Dengue, or Zika viruses. Scientists have now identified key ways the three viruses hijack the body's cells, and they found at least one potential drug that can disrupt this process in human cells.
Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and monkeys from the infection.
Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.
Our conferences aim to bring together physicians, public health practitioners and researchers in various related fields in order to share knowledge, discuss new findings and new ways to further proceed, with the goal of creating valuable collaborations. The content of this conference will include: epidemiology and clinical aspects of Aedes related infections, gynecological aspects and follow up with children born to Zika infected mothers.
A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.